PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MS patients did not benefit from CCSVI intervention

Procedure is safe but does not improve MS outcomes, a finding that the UB investigators call 'surprising and unexpected'

2013-03-15
(Press-News.org) BUFFALO, N.Y. – The first controlled clinical trial to test the safety and efficacy of interventional endovascular therapy on the symptoms and progression of multiple sclerosis has found that the intervention, sometimes called the "liberation treatment," which has attracted intense interest in the global MS community, does not improve patient outcomes. In a few cases, the treatment made symptoms worse.

University at Buffalo researchers will present their results in an "Emerging Science" poster session March 20 at the annual American Academy of Neurology meeting in San Diego. They discuss the findings in this video (http://youtu.be/94gLM4QlU_A).

The Prospective Randomized Endovascular Therapy in MS (PREMiSe) trial is believed to be the first prospective randomized double-blinded, controlled study of balloon angioplasty for MS being performed with Institutional Review Board approval in a rigorous fashion in the U.S. with significant safeguards in place to ensure careful determination of risks and benefits. All screening, diagnostic, interventional and follow-up procedures and visits were performed at no cost to the patients.

The study's key findings are that while the treatment is safe and was not associated with serious adverse events, it did not provide sustained improvement in MS patients.

Based on their findings, the UB researchers' primary message to MS patients and their doctors is that endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI) should only be done in the context of randomized, double-blinded, controlled studies like PREMiSe.

"Our strong recommendation to patients and to practitioners, who have, in earnest, been seeking betterment for their disease and a cure for MS is that they should instead consider enrolling in trials, rather than undergoing these procedures on a fee-for-service basis," said Adnan Siddiqui, MD, assistant professor of neurosurgery, UB School of Medicine and Biomedical Sciences and PREMiSe principal investigator.

Since 2009, approximately 30,000 MS patients worldwide have undergone the endovascular procedure that opens blockages in veins that drain blood from the brain. The vast majority of these procedures were done on a fee-for-service basis, and not as part of clinical trials.

The idea for PREMiSe took shape as a collaboration between the UB Department of Neurosurgery and the UB Department of Neurology at the suggestion of L. Nelson Hopkins, MD, SUNY Distinguished Professor and chair of neurosurgery, who is co-principal investigator.

The researchers at the UB School of Medicine and Biomedical Sciences were "uniquely situated" to study this important question, Siddiqui said. "Here at UB, some of the world's leaders in stroke intervention, in the Department of Neurosurgery, are located right next door to some of the world leaders in multiple sclerosis in the UB Department of Neurology and in imaging at the Buffalo Neuroimaging Analysis Center (BNAC)," he said.

Researchers at UB's BNAC have published or presented more than 25 studies on CCSVI and its relationship to neurological diseases including MS.

"Our findings over the last three years have indicated that CCSVI is more prevalent in MS patients than in healthy controls but the cause or consequence of these venous abnormalities has not been established," said Robert Zivadinov, MD, PhD, FAAN, UB professor of neurology, director of the BNAC and co-principal investigator on the study.

The endovascular intervention is based on the hypothesis that the narrowing in the large veins in the neck and chest might cause improper drainage of blood from the brain, resulting in eventual injury to brain tissue, Zivadinov explained. It was thought that angioplasty -- treatment commonly used by cardiologists and other endovascular surgeons to treat atherosclerosis -- may remedy the blockages.

"The whole idea of PREMiSe was to find out if opening up the veins that drain blood from the brain and the spinal cord would improve outcomes for MS patients," said Bianca Weinstock-Guttman, MD, UB professor of neurology and director of UB's MS Center.

"What we found was rather surprising and unexpected," Siddiqui said. "It was quite the opposite of what we originally expected to find. The study showed that endovascular treatment of stenosed veins had no effect in MS patients."

A total of 30 MS patients, most of whom were from Western New York, were studied in the PREMiSe trial. Phase 1 was a safety trial, involving 10 MS patients and Phase II involved a total of 20 MS patients, who were randomized to receive treatment or placebo.

The UB researchers found no difference in clinical symptoms, brain lesions as determined on MRIs or quality of life outcomes between MS patients who underwent balloon angioplasty to correct CCSVI and those who did not receive the treatment.

The researchers stressed that the UB study was small and that larger studies should be undertaken and should be conducted in a rigorous fashion with IRB approval, as was PREMiSe.

"This is not the last word on this endovascular treatment for MS," Siddiqui concluded. "This is the first word because this was the first double-blinded, randomized sham-controlled trial on the subject. However, these findings lead us to caution strongly against the general acceptance of this invasive procedure for MS patients."

### In addition to Siddiqui, Zivadinov, Weinstock-Guttman and Hopkins, Ralph H.B. Benedict, PhD, UB professor of neurology and Elad Levy, MD, UB associate professor of neurosurgery contributed significantly to the study design and interpretation of the findings. Other UB co-investigators are Yuval Karmon, Jihnhee Yu, Karen Marr, Vesela Valnarov, Murali Ramanathan, Deepa P. Ramasmamy, Kresimir Dolic, David Hojnacki, Ellen Carl and Cheryl Kennedy.

The study was funded by Kaleida Health, UB, the Direct MS Foundation (Canada), Volcano Corp, ev3 Corp and many individuals who have a personal stake in MS research. END


ELSE PRESS RELEASES FROM THIS DATE:

Inspired by deep sea sponges: Creating flexible minerals

2013-03-15
Scientists at Johannes Gutenberg University Mainz (JGU) and the Max Planck Institute for Polymer Research (MPI-P) in Germany have created a new synthetic hybrid material with a mineral content of almost 90 percent, yet extremely flexible. They imitated the structural elements found in most sea sponges and recreated the sponge spicules using the natural mineral calcium carbonate and a protein of the sponge. Natural minerals are usually very hard and prickly, as fragile as porcelain. Amazingly, the synthetic spicules are superior to their natural counterparts in terms of ...

Improved detection of frontotemporal degeneration may aid clinical trial efforts

2013-03-15
SAN DIEGO - A series of studies demonstrate improved detection of the second most common form of dementia, providing diagnostic specificity that clears the way for refined clinical trials testing targeted treatments. The new research is being presented by experts from the Perelman School of Medicine at the University of Pennsylvania at the American Academy of Neurology's 65th Annual Meeting in San Diego March 16-23, 2013. Frontotemporal degeneration, the most common dementia in people under 60, can be hereditary or sporadic in nature and caused by one of two different ...

Telestroke program increases access to stroke care by 40 percent

2013-03-15
SAN DIEGO - Telestroke programs substantially improve access to life-saving stroke care, extending coverage to less populated areas in an effort to reduce disparities in stroke care access. A new study by researchers from the Perelman School of Medicine at the University of Pennsylvania, being presented at the American Academy of Neurology's 65th Annual Meeting in San Diego March 16-23, 2013, found that telemedicine programs in Oregon pushed stroke coverage into previously uncovered, less populated areas and expanded coverage by approximately 40 percent. "Telestroke ...

Discovery could yield treatment for cocaine addicts

2013-03-15
EAST LANSING, Mich. --- Scientists have discovered a molecular process in the brain triggered by cocaine use that could provide a target for treatments to prevent or reverse addiction to the drug. Reporting in the Journal of Neuroscience, Michigan State University neuroscientist A.J. Robison and colleagues say cocaine alters the nucleus accumbens, the brain's pleasure center that responds to stimuli such as food, sex and drugs. "Understanding what happens molecularly to this brain region during long-term exposure to drugs might give us insight into how addiction occurs," ...

'Dirty blizzard' in Gulf may account for missing Deepwater Horizon oil

2013-03-15
TALLAHASSEE, Fla. — Oil from the 2010 Deepwater Horizon spill acted as a catalyst for plankton and other surface materials to clump together and fall to the sea floor in a massive sedimentation event that researchers are calling a "dirty blizzard." Jeff Chanton, the John Widmer Winchester Professor of Oceanography in the Department of Earth, Ocean and Atmospheric Science at Florida State University, is one of the members of the Deep-C Consortium who presented the dirty blizzard hypothesis at a recent conference in New Orleans that focused on the effects of the oil spill ...

Tau transmission model opens doors for new Alzheimer's, Parkinson's therapies

2013-03-15
SAN DIEGO – Injecting synthetic tau fibrils into animal models induces Alzheimer's-like tau tangles and imitates the spread of tau pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania being presented at the American Academy of Neurology's 65th Annual Meeting in San Diego March 16-23, 2013. This Alzheimer's research, along with additional Parkinson's research from Penn and beyond, further demonstrates the cell-to-cell transmission of neurodegenerative proteins. John Q. Trojanowski, MD, PhD, co-director of the Center for ...

Kessler Foundation researchers share findings in rehabilitation research at AAN meeting in San Diego

2013-03-15
West Orange, NJ. March 15, 2013. Kessler Foundation scientists and their colleagues will discuss their progress in rehabilitation research at the upcoming 65th Annual American Academy of Neurology Conference at the San Diego Convention Center in San Diego, CA, March 16 – 23. A.M. Barrett, MD, director of Stroke Rehabilitation at Kessler Foundation will present on Pharmacologic Enhancement of Stroke Rehabilitation on Friday March 22, 2013 as part of a Specialty in Focus session on Neurorehabilitation Enhancement Techniques. This session addresses the contribution of brain ...

Study offers new insights on invasive fly threatening US fruit crops

Study offers new insights on invasive fly threatening US fruit crops
2013-03-15
Humans aren't the only species with a sweet tooth. Research from North Carolina State University shows that the invasive spotted-wing vinegar fly (Drosophila suzukii) also prefers sweet, soft fruit – giving us new insight into a species that has spread across the United States over the past four years and threatens to cause hundreds of millions of dollars in damage to U.S. fruit crops. "Because we know that D. suzukii prefers softer, sweeter fruit, we can focus our research efforts into which wild fruits may serve as reservoirs for this species and help identify new crops ...

Report: Communications technology among tools needed to aid miner safety

2013-03-15
COLUMBUS, Ohio—A new National Academy of Sciences report identifies tools that would help miners devise their own means of escape when trapped underground. In part, the report suggests that The National Institute of Occupational Safety and Health (NIOSH) and the Mine Safety and Health Administration (MSHA) work closely with technology companies to develop new communications and tracking devices—ones that keep working underground after a mining accident. It also suggests that NIOSH and MSHA work with mining companies to enable frequent escape drills and extensive training ...

Mindfulness at school reduces likelihood of depression-related symptoms in adolescents

2013-03-15
Mindfulness is a form of meditation therapy focused on exercising 'attentiveness'. Depression is often rooted in a downward spiral of negative feelings and worries. Once a person learns to more quickly recognise these feelings and thoughts, he or she can intervene before depression sinks in. While mindfulness has already been widely tested and applied in patients with depression, this is the first time the method has been studied in a large group of adolescents in a school-based setting, using a randomised controlled design. The study was carried out at five middle schools ...

LAST 30 PRESS RELEASES:

New software tool could help better understand childhood cancer

Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility

Women 65+ still at heightened risk of cervical cancer caused by HPV

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

Effective therapies needed to halt rise in eco-anxiety, says psychology professor

Nature-friendly farming boosts biodiversity and yields but may require new subsidies

Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals

Microplastics discovered in human reproductive fluids, new study reveals

Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa

Novel flu vaccine adjuvant improves protection against influenza viruses, study finds

Manipulation of light at the nanoscale helps advance biosensing

New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance

New study links blood metabolites and immune cells to increased risk of urolithiasis

Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2

New insights into the clinical impact of IKBKG mutations: Understanding the mechanisms behind rare immunodeficiency syndromes

Displays, imaging and sensing: New blue fluorophore breaks efficiency records in both solids and solutions

Sugar, the hidden thermostat in plants

Personality can explain why some CEOs earn higher salaries

This puzzle game shows kids how they’re smarter than AI

Study suggests remembrances of dead played role in rise of architecture in Andean region

Brain stimulation can boost math learning in people with weaker neural connections

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds

Neurotechnology reverses biological disadvantage in maths learning

UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning

Scientists target ‘molecular machine’ in the war against antimicrobial resistance

Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting

Aston University research: Parents should encourage structure and independence around food to support children’s healthy eating

Thunderstorms are a major driver of tree death in tropical forests

Danforth Plant Science Center adds two new faculty members

Robotic eyes mimic human vision for superfast response to extreme lighting

[Press-News.org] MS patients did not benefit from CCSVI intervention
Procedure is safe but does not improve MS outcomes, a finding that the UB investigators call 'surprising and unexpected'